# Safety and Immunogenicity of a Plasmid HIV Vaccine in HIV Uninfected Adults

> **NCT00249106** · PHASE1 · COMPLETED · sponsor: **International AIDS Vaccine Initiative** · enrollment: 45 (actual)

## Conditions studied

- HIV Infection

## Interventions

- **BIOLOGICAL:** ADVAX

## Key facts

- **NCT ID:** NCT00249106
- **Lead sponsor:** International AIDS Vaccine Initiative
- **Sponsor class:** NETWORK
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12
- **Primary completion:** 2005-10
- **Final completion:** 2005-10
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2013-02-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00249106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00249106, "Safety and Immunogenicity of a Plasmid HIV Vaccine in HIV Uninfected Adults". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00249106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*